Recognized globally as experts in neurocognition and pharmacologic treatment of CNS disorders, the NeuroCog Trials Scientific Team has been instrumental in hundreds of research projects and clinical trials. Below are links to key articles that comprise a portion of our scientific library.

Cognitive burden of anticholinergic medications in psychotic disorders

Posted

Patients with psychotic disorders are often treated with numerous medications, many of which have anticholinergic activity. We assessed cognition in relation to the cumulative anticholinergic burden of multiple drugs included in treatment regimens of participants from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Clinically … Continued

Tagged: , , , , ,

Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia

Posted

The Schizophrenia Cognition Rating Scale (SCoRS) is an interview-based assessment of cognition that involves interviews with patients and informants. The SCoRS has shown good reliability, validity, and sensitivity to cognitive impairment in schizophrenia, with the advantage of brief administration and scoring time. The present study … Continued

Tagged: , , , ,

Validation of the tablet-administered Brief Assessment of Cognition (BAC App)

Posted

The validation study of our proprietary Brief Assessment of Cognition (BAC App) is now in press in Schizophrenia Research, available as Open Access PDF. To facilitate the administration of our widely-used pen-and-paper neurocognitive battery, the Brief Assessment of Cognition (BAC), we developed a regulatory compliant … Continued

Tagged: , , ,
Page 1 Page 2 Page 3 Page 22